Fresenius SE & Co KGaA - Company Profile
Powered by
All the data and insights you need on Fresenius SE & Co KGaA in one report.
- Save hours of research time and resources with
our up-to-date Fresenius SE & Co KGaA Strategy Report
- Understand Fresenius SE & Co KGaA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Fresenius SE & Co KGaA (Fresenius) is a global healthcare group that offers products and services for dialysis, hospitals, and outpatient treatment. It provides various dialysis services through its own clinics and sells products to other dialysis service providers. Its major products and services include machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and post-acute care hospitals in Germany through Helios Kliniken Group. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.
Fresenius SE & Co KGaA premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Fresenius Medical Care: | End-Stage Renal Disease-related treatments | Actemra |
Peritoneal Dialysis Cyclers | End-Stage Renal Disease-related laboratory testing services | RoActemra |
Hemodialysis Machines | Pharmacy services | Granuflo |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In January, the company entered into an agreement to sell Vamed for US$653.6 million. |
2023 | New Products/Services | In November, Fresenius Kabi launched Tyenne. |
2023 | Others | In November, the company completed the deconsolidation of Fresenius Medical Care. |
Competitor Comparison
Key Parameters | Fresenius SE & Co KGaA | Baxter International Inc | DaVita Inc | Nipro Corp | Geratherm Medical AG |
---|---|---|---|---|---|
Headquarters | Germany | United States of America | United States of America | Japan | Germany |
City | Bad Homburg | Deerfield | Denver | Settsu-Shi | Geschwenda |
State/Province | Hessen | Illinois | Colorado | Osaka | Thuringen |
No. of Employees | 193,865 | 60,000 | 70,000 | 38,770 | 188 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Michael Sen | Chief Executive Officer; Chairman | Executive Board | 2023 | 56 |
Sara Hennicken | Chief Financial Officer | Senior Management | 2022 | 42 |
Michael Moser | Head - Legal, Compliance, Risk Management, ESG, Human Resources, and Fresenius Vamed | Senior Management | 2023 | 47 |
Pierluigi Antonelli | Chief Executive Officer - Fresenius Kabi | Senior Management | 2023 | 56 |
Robert Moller | Chief Executive Officer - Helios Health GmbH | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer